Delivery Order SPE2DB20D2104-SPE2DB25FMERG

Award Date 12/20/24
Potential Completion Date 12/23/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,756.92, is a delivery order contract with a firm fixed price pricing type. The contract is for the provision of 4567678475 ! VEVYE 0.1% EYE DROP 2ML, with a period of performance through March 25, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,274.78 Firm Fixed Price delivery order contract covers the procurement of 4567441115 ! MIEBO 100% EYE DROP 3ML medical supplies. The contract has an ultimate completion date of March 4, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,223.59 firm-fixed-price delivery order covers the provision of a pharmaceutical product described as "4566758291 ! XDEMVY 0.25% DROP 10ML." The contract has an ultimate completion date of January 10, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,028.88 firm fixed-price delivery order contract is for the provision of 4567732443 ! VEVYE 0.1% EYE DROP 2ML, with a period of performance through March 31, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,223.59, is a Delivery Order with a Firm Fixed Price pricing type. It covers the delivery of a pharmaceutical product, "4566759035 ! XDEMVY 0.25% DROP 10ML", with a completion date of January 10, 2025. The contract is not designated with a set-aside requirement, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,365.42 firm fixed-price delivery order covers the supply of a medical product labeled "4566178696 ! XDEMVY 0.25% DROP 10ML" with an ultimate completion date of November 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award, valued at $1,227.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, a delivery order under the DLA's Indefinite Delivery Contract (IDC) valued at $999,999,999, covers the procurement of 4566422753 VEVYE 0.1% EYE DROP 2ML, a pharmaceutical product. The IDC serves as a primary vehicle for DLA to obtain a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $6,417.14, was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567721820 ! VEVYE 0.1% EYE DROP 2ML, a pharmaceutical product, with a completion date of March 28, 2025. The contract is a Firm Fixed Price Delivery Order and was not set aside for any specific type of business. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is a delivery order worth $5,867.34 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MIEBO 100% EYE DROP 3ML medical products, with a period of performance through November 7, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,758.18, is for the delivery of 4567503375 ! VEVYE 0.1% EYE DROP 2ML, a pharmaceutical product. The contract has an ultimate completion date of March 10, 2025 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMERG
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,122.18, is a Firm Fixed Price Delivery Order with a completion date of December 23, 2024. The contract covers the delivery of the medical product "4566778896 ! VEVYE 0.1% EYE DROP 2ML" and does not have a set-aside designation, indicating open competition.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/21/25, 9:54 AM